drugset / Trial / NCT01255475

Blood Pressure Reduction in Heart Failure

NCT01255475

RandomizedParallel-groupTriple-blindTreatment

Summary

Previous studies have demonstrated a direct association between blood pressure level and cardiovascular risk. However in patients with heart failure this association is considered controversial. The aim of this study is to evaluate the effect of the reduction of blood pressure in patients with heart failure. The investigators will examine the effects of this intervention over mortality, quality of life, and cardiac function.

Timeline

Start
2011-01
Primary completion
2012-10
Completion
2013-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Amlodipine Other / unclassified 10 mg
Subject Hydralazine Small molecule 100 mg